AEON Biopharma, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 30 →InsidersNo open-market buys or sales.→HoldersDauntless Investment 47.5%Geode 0.4%Vanguard 0.3%→Financing →PeersClosest companies: AQST, AXSM, ABOS→
From the filings
Figures
- Net income
- −$54.6Mlast 12 months
- Operating cash flow
- −$12.0Mlast 12 months
- Cash and equivalents
- $3.4Mat the last balance sheet
- Shares outstanding
- 26.3M shareson issue